During the past decade, Worcestershire Acute Hospitals NHS Trust conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Worcestershire Acute Hospitals NHS Trust" #1 sponsor was "Celgene" with 2 trials, followed by "Imperial College London" with 2 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "PharmaMar" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Worcestershire Acute Hospitals NHS Trust" #1 collaborator was "Universidad de Granada" with 2 trials as a collaborator, "University of Edinburgh" with 2 trials as a collaborator, "University of Manchester" with 2 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator and "Cancer Research UK" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Worcestershire Acute Hospitals NHS Trust" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Familial Hypercholesterolemia" (2 trials), "Multiple Myeloma" (2 trials), "Allograft" (1 trials) and "Arthritis, Inflammatory" (1 trials). Many other conditions were trialed in "Worcestershire Acute Hospitals NHS Trust" in a lesser frequency.

Most popular intervention types in "Worcestershire Acute Hospitals NHS Trust" are "Drug" (8 trials), "Other" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "ALN-PCSSC" (1 trials), "Ankle Brachial Pressure Index (ABPI)" (1 trials), "Audible handheld Doppler" (1 trials), "Bococizumab (PF-04950615; RN316)" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Worcestershire Acute Hospitals NHS Trust" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Worcestershire Acute Hospitals NHS Trust". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Worcestershire Acute Hospitals NHS Trust, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Worcestershire Acute Hospitals NHS Trust, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".